Gamble Jones Investment Counsel decreased its stake in shares of Danaher Co. (NYSE:DHR) by 25.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 4,115 shares of the conglomerate’s stock after selling 1,410 shares during the quarter. Gamble Jones Investment Counsel’s holdings in Danaher were worth $594,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Howe & Rusling Inc. lifted its holdings in Danaher by 116.3% in the third quarter. Howe & Rusling Inc. now owns 186 shares of the conglomerate’s stock worth $27,000 after acquiring an additional 100 shares during the last quarter. Next Capital Management LLC bought a new position in Danaher in the second quarter worth about $31,000. Litman Gregory Asset Management LLC bought a new position in Danaher in the second quarter worth about $33,000. Altshuler Shaham Ltd lifted its holdings in Danaher by 59.3% in the second quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 89 shares during the last quarter. Finally, Pinnacle Bank lifted its holdings in Danaher by 52.3% in the third quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock worth $38,000 after acquiring an additional 90 shares during the last quarter. 78.30% of the stock is currently owned by institutional investors and hedge funds.
In other news, Chairman Mitchell P. Rales purchased 2,500 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were bought at an average price of $139.52 per share, for a total transaction of $348,800.00. Following the completion of the purchase, the chairman now owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 11.40% of the stock is currently owned by company insiders.
Shares of NYSE:DHR traded up $0.73 during trading hours on Friday, hitting $135.23. The stock had a trading volume of 1,633,369 shares, compared to its average volume of 2,487,994. The stock’s fifty day simple moving average is $139.07 and its 200 day simple moving average is $138.28. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $147.33. The firm has a market capitalization of $95.87 billion, a price-to-earnings ratio of 29.92, a PEG ratio of 2.24 and a beta of 0.92. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.09 and a current ratio of 3.43.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, October 24th. The conglomerate reported $1.16 EPS for the quarter, beating the consensus estimate of $1.15 by $0.01. Danaher had a net margin of 12.13% and a return on equity of 11.42%. The company had revenue of $5.04 billion for the quarter, compared to analyst estimates of $5.02 billion. During the same quarter last year, the business earned $1.10 earnings per share. Danaher’s revenue was up 3.8% compared to the same quarter last year. As a group, research analysts anticipate that Danaher Co. will post 4.76 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.17 dividend. The ex-dividend date of this dividend was Thursday, September 26th. This represents a $0.68 annualized dividend and a dividend yield of 0.50%. Danaher’s payout ratio is currently 15.04%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: What is a Derivative?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.